MedTrace Logo

Application of TMS Coupled With VR for Slowing the Rate of Cognitive Decline in Patients With Alzheimer's Disease

NCT04440891 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-08-14

No results posted yet for this study

Summary

This is a randomized sham control study to evaluate how repetitive Transcranial Magnetic Stimulation (rTMS), interactive cognitive training, or the combination of rTMS and cognitive training reduce the cognitive decline of patients diagnosed with Alzheimer's disease

Conditions

  • Alzheimer Disease

Interventions

DEVICE

TMS stimulation with X-Torp task

TMS-Stimulation with X-Torp task

DEVICE

TMS-Stimulation with MindMotion Go

TMS-Stimulation with MindMotion Go

DEVICE

TMS-Sham with X-Torp task

TMS-Sham with X-Torp task

DEVICE

TMS-Sham with MindMotion Go

TMS-Sham with MindMotion Go

Sponsors & Collaborators

  • Ali Rezai

    lead OTHER

Principal Investigators

  • Marc Haut, PhD · Rockefeller Neuroscience Institute

  • Victor Finomore, PhD · Rockefeller Neuroscience Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-03
Primary Completion
2021-11-02
Completion
2021-11-02
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04440891 on ClinicalTrials.gov